Global Pharmaceutical Intermediates Market

Pharmaceutical Intermediates Market Size, Share, Growth Analysis, By Product(Chemical intermediates, Bulk drug intermediates, and Custom intermediates), By Application(Analgesics, Anti-inflammatory drug, Cardiovascular drugs, Anti-diabetic drugs), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35I2111 | Region: Global | Published Date: July, 2024
Pages: 157 | Tables: 65 | Figures: 75

Pharmaceutical Intermediates Market Insights

Pharmaceutical Intermediates Market size was valued at USD 29 billion in 2021 and is poised to grow from USD 30.6 billion in 2022 to USD 52.6 billion by 2030, growing at a CAGR of 6.3% in the forecast period (2023-2030).

Pharmaceutical intermediates are drugs that are used as raw materials in the manufacture of bulk drugs. They are commonly used to refer to the material formed during the synthesis of the active pharmaceutical ingredient (API) prior to the processing of the API. These are usually made from high-quality basic ingredients. The intermediates are widely used in the pharmaceutical and cosmetic industries. The global market is developing due to the increasing demand in these industries. These are widely used for research and development in the pharmaceutical industry. Pharmaceutical intermediates are produced using basic materials such as coal tar or petroleum to make pesticides, drugs, resins, additives, plasticizers, and other products. However, various intermediate products can be produced during organic synthesis and used to make various drugs.

Increasing production of active pharmaceutical ingredients is driving global pharmaceutical intermediates market. The growing trend of high-tech therapies with advanced delivery systems and the development of personalized and customized medicines are increasing the demand for active pharmaceutical ingredients worldwide. The high cost associated with the acquisition of biopharmaceutical drugs is a major factor hampering the growth of global market. Also, the high capital investment required for the production of APIs is a major restraining factor that may hamper market growth. The introduction of new technologies in the pharmaceutical industry for manufacturing various drugs, as well as increased investment in research activities, is expected to provide significant growth opportunities for the market in the coming years.

US Pharmaceutical Intermediates Market is poised to grow at a sustainable CAGR for the next forecast year.

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Pharmaceutical Intermediates Market size was valued at USD 29 billion in 2021 and is poised to grow from USD 30.6 billion in 2022 to USD 52.6 billion by 2030, growing at a CAGR of 6.3% in the forecast period (2023-2030).

pharmaceutical intermediates market is highly competitive with the presence of local as well as companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of pharmaceutical intermediates market. 'BASF SE', 'Lonza Group AG', 'Thermo Fisher Scientific Inc.', 'Wuxi AppTec Co. Ltd.', 'Merck KGaA', 'Dishman Group', 'Codexis Inc.', 'Cambrex Corporation', 'Hikal Ltd.', 'Chemcon Speciality Chemicals Ltd.', 'Porton Fine Chemicals Ltd.', 'Divis Laboratories Ltd.', 'Pfizer CentreOne', 'Aurobindo Pharma Ltd.', 'Sanofi SA', 'Lianhe Chemical Technology Co. Ltd.', 'Jiangsu Hengrui Medicine Co. Ltd.', 'Shandong Xinhua Pharmaceutical Co. Ltd.', 'WuXi STA', 'Zhejiang NHU Co. Ltd.'

Increasing Incidence of Chronic Diseases

The cost of heart disease to the nation's health care system is increasing. A key trend in the pharmaceutical intermediates market is the rise in chronic cardiovascular conditions such as heart failure and coronary artery disease. According to a paper published in July 2020 in the Curious Journal of Medical Science, ischemic heart disease (IHD) is the leading cause of death worldwide. Ischemic heart disease affects about 126 million people globally. It is expected that by 2030, there will be more than 1,845 cases of ischemic heart disease per 100,000 persons worldwide.

On the basis of region, pharmaceutical intermediates market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America dominated the pharmaceutical intermediates market and is expected to maintain its dominance during the forecast period. North America is dominating the market due to the presence of various pharmaceutical companies, research centres, and laboratories, and rapidly growing CMOs & CROs in the US and Canada. Also, rising investments by the government and private players to boost the growth of the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.


Feedback From Our Clients

Global Pharmaceutical Intermediates Market

Report ID: SQMIG35I2111